John Michael Bernard, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1309 W. Fairmont Pkway, Laporte, TX 77056 Phone: 281-470-0543 |
News Archive
Medtronic, Inc. today announced the global launch of the Defeat-HF (Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Heart Failure) clinical trial. It is the industry's first prospective, randomized study evaluating the clinical feasibility of spinal cord stimulation, or neurostimulation, to improve clinical signs and symptoms of heart failure.
A new survey shows a majority of new and expectant moms have not discussed preterm birth with their healthcare providers, despite the fact that early prenatal care, including discussion about lifestyle habits and medical history, may give babies a better chance of a healthy, full-term birth. This new survey, titled SPEAKing About Preterm Birth, was conducted among moms and healthcare providers including obstetricians/gynecologists and maternal fetal medicine specialists, by the March of Dimes and BabyCenter, and sponsored by Ther-Rx Corporation.
Mylan Laboratories has announced that the U.S. Food and Drug Administration (FDA) has confirmed Mylan's current status as the only approved ANDA for all strengths of Amlodipine Besylate Tablets.
Scientists at the University of Aberdeen have been awarded £196,166 to help fund pioneering research, which is exploring a method of combating certain conditions and diseases such as asthma and multiple sclerosis.
› Verified 5 days ago